Vanguard Group Inc Aldeyra Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,501,593 shares of ALDX stock, worth $19.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,501,593

Previous 3,718,018 5.82%

Holding current value

$19.4 Million

Previous $21.4 Million 37.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$1.42 - $5.48 $307,323 - $1.19 Million	-216,425 Reduced 5.82%	3,501,593 $13.4 Million
Q1 2025 May 09, 2025	SELL	$4.7 - $6.98 $182,219 - $270,614	-38,770 Reduced 1.03%	3,718,018 $21.4 Million
Q4 2024 Feb 11, 2025	SELL	$4.21 - $5.9 $16,128 - $22,602	-3,831 Reduced 0.1%	3,756,788 $18.7 Million
Q3 2024 Nov 13, 2024	BUY	$3.19 - $6.32 $58,163 - $115,232	18,233 Added 0.49%	3,760,619 $20.3 Million
Q2 2024 Aug 13, 2024	SELL	$3.25 - $4.72 $411,752 - $597,990	-126,693 Reduced 3.27%	3,742,386 $12.4 Million
Q1 2024 May 10, 2024	SELL	$2.77 - $4.22 $162,094 - $246,945	-58,518 Reduced 1.49%	3,869,079 $12.7 Million
Q4 2023 Feb 14, 2024	BUY	$1.47 - $6.06 $1.09 Million - $4.49 Million	740,177 Added 23.22%	3,927,597 $13.8 Million
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $44,150 - $58,964	7,226 Added 0.23%	3,187,420 $21.3 Million
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $4.84 Million - $8.1 Million	681,033 Added 27.25%	3,180,194 $26.7 Million
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $39,766 - $68,437	6,892 Added 0.28%	2,499,161 $24.8 Million
Q4 2022 Feb 10, 2023	SELL	$5.08 - $7.09 $119,964 - $167,430	-23,615 Reduced 0.94%	2,492,269 $17.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $300,678 - $612,435	79,126 Added 3.25%	2,515,884 $13.4 Million
Q2 2022 Aug 12, 2022	SELL	$2.43 - $4.85 $1.28 Million - $2.55 Million	-524,877 Reduced 17.72%	2,436,758 $9.72 Million
Q1 2022 May 13, 2022	BUY	$3.25 - $5.17 $480,060 - $763,665	147,711 Added 5.25%	2,961,635 $13.2 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $302,848 - $833,264	86,528 Added 3.17%	2,813,924 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$7.94 - $11.31 $245,711 - $349,999	30,946 Added 1.15%	2,727,396 $23.9 Million
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $28.2 Million - $40 Million	2,696,450 New	2,696,450 $30.6 Million

Others Institutions Holding ALDX

# of Institutions

135

Shares Held

34.9M

Call Options Held

244K

Put Options Held

51.6K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $323M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Aldeyra Therapeutics, Inc. Transaction History